Long-term treatment with arsenite activates HER1 and HER2 through upregulating EGF, TGFα, and HSP90 in a human uroepithelial cell line.

MLA

Jin, Peiyu, et al. “Long-Term Treatment with Arsenite Activates HER1 and HER2 through Upregulating EGF, TGFα, and HSP90 in a Human Uroepithelial Cell Line.” Cell Biology and Toxicology, vol. 36, no. 3, June 2020, pp. 279–84. EBSCOhost, https://doi.org/10.1007/s10565-019-09500-9.

APA

Jin, P., Liu, J., Zhou, Q., Li, S., Liu, W., & Xi, S. (2020). Long-term treatment with arsenite activates HER1 and HER2 through upregulating EGF, TGFα, and HSP90 in a human uroepithelial cell line. Cell Biology and Toxicology, 36(3), 279–284. https://doi.org/10.1007/s10565-019-09500-9

Chicago

Jin, Peiyu, Jieyu Liu, Qing Zhou, Sihao Li, Weijue Liu, and Shuhua Xi. 2020. “Long-Term Treatment with Arsenite Activates HER1 and HER2 through Upregulating EGF, TGFα, and HSP90 in a Human Uroepithelial Cell Line.” Cell Biology and Toxicology 36 (3): 279–84. doi:10.1007/s10565-019-09500-9.